Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...

On May 13, 2025, the Company and ITIL entered into an amended and restated promissory note (the“A&R Note”) and a letter agreement ... In connection with the extension, ITIL agreed in the ...

The original promissory notes were issued to Inscobee Inc. on May 20, 2024, and August 19, 2024, in the principal amounts of $100,000 and $150,000, respectively. Another note was issued to Apimeds ...

The original promissory notes were issued to Inscobee Inc. on May 20, 2024, and August 19, 2024, in the principal amounts of $100,000 and $150,000, respectively. Another note was issued to Apimeds ...

Petitioners were not entitled to interest deductions claimed on promissory notes related to a complex financial transaction, as the notes did not constitute genuine indebtedness for tax purposes, held ...